AtriCure (FRA:A5I) Other Current Receivables: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A5I AtriCure Inc FRA:A5I
26 GF Score
Price €32.40
GF Value €32.94
! 5 Warning Signs
View Full Analysis

What is AtriCure Other Current Receivables?

AtriCure FRA:A5I -6.36% 26 Other Current Receivables is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:A5I with a GF Score™ of 26/100 and a GF Value™ of €32.94. The stock has 5 warning signs investors should review.

AtriCure's Other Current Receivables for the quarter that ended in Jun. 2026 was €0.0 Mil.

AtriCure Other Current Receivables Related Terms

AtriCure Other Current Receivables Historical Data

* Premium members only.

The historical data trend for AtriCure's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure Other Current Receivables Chart

AtriCure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AtriCure Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:A5I
26GF Score
AtriCure Inc FRA:A5I
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtriCure Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.0 Mil mean?
AtriCure (FRA:A5I) has a Other Current Receivables of €0.0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on AtriCure and its competitors.
Is AtriCure's Other Current Receivables too high?
AtriCure's current Other Current Receivables is €0.0 Mil. Overall, AtriCure has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does AtriCure's Other Current Receivables compare to BLFS and PLSE?
AtriCure's Other Current Receivables of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on AtriCure and its competitors. AtriCure's current Other Current Receivables is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtriCure stock overvalued right now?
AtriCure (FRA:A5I) has a current Other Current Receivables of €0.0 Mil. The stock's GF Value™ is €32.94, compared to a current price of €32.40 — trading 1.6% below its estimated fair value. The current Other Current Receivables is €0.0 Mil. AtriCure's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For AtriCure (FRA:A5I), the current Other Current Receivables is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AtriCure (FRA:A5I) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of €32.40 is trading 1.6% below its estimated GF Value™ of €32.94.

Key valuation signals for FRA:A5I:

  • Other Current Receivables: €0.0 Mil
  • GF Value™: €32.94 vs. price of €32.40 (1.6% below fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the FRA:A5I stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtriCure Business Description

Other Exchanges ATRC:USA
Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
26GF Score

Get the complete analysis for FRA:A5I

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.40
Price
€32.94
GF Value